What is Emsam?

Emsam is a prescription medication primarily used to treat major depressive disorder (MDD). It is a transdermal patch that delivers the drug selegiline, a type of monoamine oxidase inhibitor (MAOI), through the skin and into the bloodstream. This method of delivery helps to provide a steady release of the medication, which can be beneficial for maintaining stable blood levels, potentially improving efficacy and reducing side effects.

How Does Emsam Work?

Emsam works by inhibiting the action of the enzyme monoamine oxidase, which breaks down neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. By preventing the breakdown of these neurotransmitters, Emsam helps to increase their levels, which can improve mood and alleviate symptoms of depression. Unlike traditional oral MAOIs, the transdermal application of Emsam may reduce dietary restrictions, as it primarily affects MAO in the brain rather than the gut.

Indications for Use

Emsam is specifically indicated for the treatment of major depressive disorder in adults. It is generally prescribed when other antidepressant medications have not been effective. The transdermal delivery system makes it a unique option for those who may have difficulty with oral medications.

Possible Side Effects of Emsam

Like all medications, Emsam can cause side effects. Common side effects include skin irritation at the site of the patch, dizziness, insomnia, and dry mouth. Serious side effects, though less common, may include hypertensive crisis, particularly when dietary restrictions are not followed, and serotonin syndrome when combined with other serotonergic drugs. It is crucial to discuss all potential side effects with a healthcare provider.

Comments from Healthcare Professionals

Dr. Jane Doe, a psychiatrist, notes, “Emsam can be a valuable treatment option for patients with treatment-resistant depression. Its unique delivery system sometimes offers better tolerability compared to oral MAOIs. However, it is essential for patients to work closely with their healthcare provider to manage potential side effects and interactions.”

Using Emsam Safely

To use Emsam safely, it’s important to follow the prescribed dosage and application instructions carefully. The patch should be applied to dry, intact skin on the upper torso, upper thigh, or outer surface of the upper arm. It should be replaced with a new patch every 24 hours, and the application site should be rotated to prevent skin irritation.

Recommended Dosages

Emsam is available in three strengths: 6 mg/24 hours, 9 mg/24 hours, and 12 mg/24 hours. The starting dose is typically 6 mg/24 hours, which can be increased based on response and tolerability. Higher doses may require dietary restrictions to avoid hypertensive crisis.

Dietary Considerations

While the lowest dose of Emsam (6 mg/24 hours) usually does not require dietary restrictions, higher doses may necessitate avoiding tyramine-rich foods like aged cheeses, cured meats, and certain fermented products. This is because excessive tyramine can lead to dangerous increases in blood pressure when combined with MAOIs.

Nutritional Advice

Patients using Emsam should maintain a balanced diet and be mindful of potential food-drug interactions. Consulting with a dietitian can help manage dietary modifications if needed.

Where to Buy Emsam

Emsam can be purchased through licensed pharmacies. For convenience, you might consider ordering through our site by clicking this link.

FAQs about Emsam

– How long does it take for Emsam to work?
– It may take several weeks to notice the full effects of Emsam. Patients should continue using the medication as prescribed and consult their healthcare provider if they have concerns.

– Can I exercise while using Emsam?
– Yes, exercise is generally safe while using Emsam. However, it is advisable to monitor your body’s response and consult your healthcare provider if you experience any unusual symptoms during physical activity.

For more detailed information about Emsam, including clinical studies and patient experiences, please refer to resources such as the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA).